Fresenius Medical Care Deutschland GmbH
Clinical trials sponsored by Fresenius Medical Care Deutschland GmbH, explained in plain language.
A dialysis care provider, subsidiary of Fresenius Medical Care.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New dialysis salt strategy aims to reduce fluid gain and dizziness Results expected Dec 2026 (estimated)
- New blood filter could improve treatment for autoimmune diseases Results expected Dec 2026 (estimated)
- New dialysis tech aims to improve waste removal for kidney patients Results expected Aug 2027 (estimated)
-
New dialysis tech aims to improve waste removal for kidney patients
Disease control Not yet recruitingThis trial tests a new feature called FlexPoint on a peritoneal dialysis machine used at home. The feature adjusts fluid volume and dwell time during treatment. Researchers will compare three different settings in 24 adults with chronic kidney disease to see which works best for …
Sponsor: Fresenius Medical Care Deutschland GmbH • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Kidney filter study tests safer dialysis for acute kidney failure
Knowledge-focused Not yet recruitingThis study looks at how well a specific kidney filter (multiFlux 160) works when used with two different blood thinners—heparin or citrate—during continuous kidney replacement therapy. The goal is to see which approach keeps the filter working effectively while avoiding side effe…
Sponsor: Fresenius Medical Care Deutschland GmbH • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC